Assessment of neurobiological diseases with magnetic resonance spectroscopy

Neurobiology of Disease

Volumn , Issue , 2007, Pages 781-792

  Alger, Jeffry R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84883901936     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088592-3/50074-8     Document Type: Chapter

References (24)

1. Maudsley A.A. Magnetic resonance spectroscopic imaging. Brain Mapping: The Methods 2002, 351-378. Academic Press, San Diego. 2nd edition. A.W. Toga, J.C. Mazziotta (Eds.).
2. Barker P.B. Fundamentals of MR spectroscopy. Clinical MR Neuroimaging: Diffusion, Perfusion and Spectroscopy 2004, Cambridge University Press, Cambridge. J.H. Gillard, A.D. Waldman, P.B. Barker (Eds.).
3. Danielsen E.R., Ross B.D. Magnetic Resonance Spectroscopy Diagnosis of Neurological Disease 1999, Marcel Dekker, New York.
4. Alger J.R. MRS of the brain. Encyclopedia of Neuro- science 2004, Elsevier Science, Amsterdam. G. Adelman, B.A. Smith (Eds.).
5. Imamura K. Proton MR spectroscopy of the brain with a focus on chemical issues. Magn. Reson. Med. 2003, 2:117-132.
6. Demougeot C., Marie C., Giroud M., Beley A. N-acetylaspartate: a literature review of animal research on ischemia. J. Neurochem. 2004, 90:776-783.
7. Alger J.R. Magnetic resonance spectroscopy and cancer. New Techniques in Oncologic Imaging 2005, Taylor & Francis CRC Press, New York. A. Padhani, P. Choyke (Eds.).
8. Alger J.R. Magnetic resonance spectroscopy of brain tumors in adults. Clinical MR Neuroimaging: Diffusion, Perfusion and Spectroscopy 2004, Cambridge University Press, Cambridge. J.H. Gillard, A.D. Waldman, P.B. Barker (Eds.).
9. Graham G.D., Kalvach P., Blamire A.M., Brass L.M., Fayad P.B., Prichard J.W. Clinical correlates of proton magnetic resonance spectroscopy findings after acute cerebral infarction. Stroke 1995, 26:225-229.
10. Barker P.B. Metabolism: magnetic resonance spectroscopy and spectroscopic imaging. Primer on Cerebrovascular Diseases 1997, 650-660. Academic Press, San Diego. K.M. A. Welch, L.R. Caplan, D.J. Reis, B.K. Siesjo, B. Weir (Eds.).
11. Novotny E.J., Fulbright R.K., Perl P.L., Fulbright R.K., Pearl P.L., Gibson K.M., Rothman D.L. Magnetic reso-nance spectroscopy of neurotransmitters in human brain. Ann. Neurol. 2003, 54(Suppl 6):S25-S31.
12. Lin A., Ross B.D., Harris K., Wong W. Efficacy of proton magnetic resonance spectroscopy in neurological diagnosis and neurotherapeutic decision making. NeuroRx 2005, 2:197-214.
13. Law M. MR spectroscopy of brain tumors. Top. Magn. Reson. Imaging 2004, 15:291-313.
14. 1HMR spectroscopy of brain tumours and masses. NMR Biomed. 2003, 16:123-131.
15. Nelson S.J. Multivoxel magnetic resonance spectroscopy of brain tumors. Mol. Cancer Ther. 2003, 2:497-507.
16. 1H-MR spectroscopy in comparison to FDG-PET and IMT-SPECT. Rofo 2004, 176:1114-1121.
17. Jacobs A.H., Kracht L.W., Gossmann A., Ruger M.A., Thomas A.V., Thiel A., Herholz K. Imaging in neurooncology. NeuroRx 2005, 2:333-347.
18. Weber R., Ramos-Cabrer P., Hoehn M. Present status of magnetic resonance imaging and spectroscopy in animal stroke models. J. Cereb. Blood Flow Metab. 2006, 26(5):591-604.
19. 1H-MR spectroscopy in the evaluation of epilepsies: what do pathological spectra stand for with regard to current results and wha. Acta Neurol. Scand. 2003, 108:223-238.
20. Briellmann R.S., Wellard R.M., Jackson G.D. Seizure-associated abnormalities in epilepsy: evidence from MR imaging. Epilepsia 2005, 46:760-766.
21. Knowlton R.C., Laxer K.D., Ende G., Hawkins R.A., Wong S.T., Matson G.B., Rowley H.A., Fein G., Weiner M.W. Presurgical multi-modality neuroimaging in electroencephalographic lateralized temporal lobe epilepsy. Ann. Neurol. 1997, 42:829-837.
22. 1H-MR spectroscopic images for presurgical evaluation. Radiology 2001, 22(4):625-631.
23. Petroff O.A. GABA and glutamate in the human brain. Neuroscientist 2002, 8:562-573.
24. De Stefano N., Bartolozzi M.L., Guidi L., Stromillo M.L., Federico A. Magnetic resonance spectroscopy as a measure of brain damage in multiple sclerosis. J. Neurol. Sci. 2005, 233:203-208.